Skip to content

Evaluation of the Clinical Performance of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses

Evaluation of the Clinical Performance of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06377488
Enrollment
176
Registered
2024-04-22
Start date
2024-04-22
Completion date
2024-06-24
Last updated
2025-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Acuity

Brief summary

This will be an open-label, 3-visit, single-arm, dispensing clinical trial to evaluate visual acuity.

Interventions

DEVICEJJVC Investigational Multifocal Toric Contact Lens manufactured in Senofilcon A (C3) material with UV blocker / HEV filter

Test Lens

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Potential subjects must satisfy all of the following criteria to be enrolled in the study: 1. Read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form. 2. Appear able and willing to adhere to the instructions set forth in this clinical protocol. 3. Be at least 40 and not more than 70 years of age at the time of screening. 4. Own a wearable pair of spectacles if required for their distance vision. 5. Be an adapted soft contact lens wearer in both eyes (i.e. worn lenses for at least 8 hours per day at least two days per week for the past 4 weeks). 6. Be already wearing a presbyopic contact lens correction (e.g., reading spectacles over contact lenses, multifocal or monovision contact lenses, etc.) or if not respond positively to at least one symptom on the Presbyopic Symptoms Questionnaire. 7. The subject's distance spherical component of their refraction must be in the range of either -1.25 D to -3.75 D, or +1.25 D to +4.25 D. 8. The subject's refractive cylinder must be in the range of -1.00 D to -1.75 D in each eye, with the cylinder axes in the range of either 90°±15° or 180°±15°. 9. The subject's ADD power must be in the range of +0.75 D to +2.50 D in each eye. 10. The subject must have best corrected distance visual acuity of 20/20-3 or better in each eye.

Exclusion criteria

Potential subjects who meet any of the following criteria will be excluded from participating in the study: The subject must not: 1. Be currently pregnant or lactating. 2. By self-report, have any systemic disease (e.g. Sjögren's Syndrome), allergies, infectious disease (e.g., hepatitis, tuberculosis), contagious immunosuppressive diseases (e.g., HIV), autoimmune disease (e.g. rheumatoid arthritis), or other diseases, which are known to interfere with contact lens wear and/or participation in the study. 3. Use systemic medications that may interfere with contact lens wear or cause blurred vision. See Section 9.1 for additional details regarding excluded systemic medications. 4. Currently use ocular medication (with the exception of rewetting drops). 5. Have any known hypersensitivity or allergic reaction to single use preservative free rewetting drops or sodium fluorescein. 6. Have had any previous, or have any planned, ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, cataract surgery, retinal surgery, etc.). 7. Have had previous eyelid injuries, surgeries or procedures which are known to have caused abnormal eyelid position or movement, by self-report. 8. Have participated in any contact lens or lens care product clinical trial within 7 days prior to study enrollment. 9. Be an employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician). 10. Have a history of amblyopia or strabismus, by self-report. 11. Have a history of herpetic keratitis, by self-report. 12. Have ocular allergies, infections or other ocular abnormalities that are known to interfere with contact lens wear and/or participation in the study. This may include, but not be limited to entropion, ectropion, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or corneal distortion. 13. Have any Grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA scale.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Eyes With Unacceptable Lens FittingUp to 2-Week Follow-upContact lens fitting acceptance was assessed for each subject eye using a biomicroscope post lens insertion at the 1-week follow-up. Lens fit was a binary variable where unacceptable lens fit=1 and acceptable lens fit=0. The proportion of eyes with unacceptable lens fit was reported. Data from the hyperope and myopes group were combined for this outcome since lens fitting characteristics are similar for these two populations.
CLUE Vision Scores2-Week Follow-upSubjective vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The average CLUE vision score for each sphere stratum (Hyperope and Myope) was reported.
Proportion of Eyes With Absolute Rotation Less Than or Equal to 10 Degrees15-minutes after lens insertionAbsolute rotation was assessed for each subject eye using a slit lamp 15-minutes after lens insertion. Acceptable absolute rotation was dichotomized into a binary response where Y=1 if absolute rotation was less than or equal to 10 degrees and Y=0 otherwise (absolute rotation greater than 10 degrees). The proportion of eyes with absolute rotation less than or equal to 10 degrees was report for each lens.
Proportion of Eyes With Rotational Stability Less Than or Equal to 5 Degrees15-minutes after lens insertionRotational Stability was assessed for each subject eye using a slit lamp 15-minutes after lens insertion. Rotational Stability was dichotomized into a binary response where Y=1 if Rotational Stability was less than or equal to 5 degrees and Y=0 otherwise (Rotational Stability greater than 5 degrees). The proportion of eyes with Rotational Stability less than or equal to 5 degrees was report for each lens.
Proportion of Eyes With Grade 3 or Higher Slit Lamp FindingsUp to 2-Week Follow-upSlit Lamp Findings (SLF) were assessed using a biomicroscope and was graded using the FDA grading scale (Grade: 0, 1,2, 3 and 4) with grade 0 represents the absence of findings and 1 to 4 representing successively worse findings (i.e. Grade 1 = trace, Grade 2 = Mild, Grade 3 = moderate and Grade 4 = severe). This was performed on each subject eye at every study visit (baseline, unscheduled visits and 1-week follow-up). The data was then dichotomized into two groups. Those with grade 3 or higher and those with grade 2 or lower. The proportion of eyes with SLF with grade 3 or higher was reported. Data from the hyperope and myopes group were combined for this outcome since the rate of SFLs grade 3+ is similar for these two populations.
HLHC Binocular logMAR Visual Acuities2-Week Follow-upBinocular visual acuity was measured on a logMAR (Logarithm of Minimal Angle of Resolution) scale under high luminance high contrast condition. At distance (4 meters), VA is assessed using ETDRS (Early Treatment Diabetic Retinopathy Study) charts; while near (40 cm) and intermediate (64 cm) assessments were made using reduced Guillon-Poling charts. Letter-by-letter results calculated the visual performance score for each chart read. LogMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR visual performance score of 0.0 is equivalent to Snellen visual acuity of 20/20. Data from hyperopes and myopes were combined for this outcome since logMAR scores between the two populations are similar.

Secondary

MeasureTime frameDescription
CLUE Comfort Scores2-Week Follow-upSubjective comfort was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The average CLUE comfort scores for each sphere stratum (Hyperope and Myope) were reported.
CLUE Handling Scores2-Week Follow-upSubjective handling was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The average CLUE handling scores for each sphere stratum (Hyperope and Myope) were reported.
Proportion of Subject Achieving Optimal Lens Pair in 4 Lenses or Less.Up to 1-Week Follow-upThe number of lenses to achieve the optimal pair for each subject was calculated as the original pair (2) plus all the required modifications to reach the optimal pair. In this study the minimum number of lenses per subject used was 2 where the maximum possible number of lenses used was 10. The data was dichotomized as Y=1 if the subject was able to achieve optimal lens pair in 4 lenses or lenses or less and 0 otherwise. A lens modification was performed if the subject reports unsatisfactory vision or was unable to obtain 20/30 distance visual acuity in both eyes. If the subject reported satisfactory vision with the lenses a modification was not required. However, based upon the investigator's findings on the measured visual acuity and/or over- refraction a modification may have been performed. Data for the hyperope and myope groups were combined for this endpoint since the number of subjects needed to optimize vision is independent of which group a subject belongs to.
CLUE Vision Scores2-Week Follow-upSubjective vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The average CLUE vision score for each sphere stratum (Hyperope and Myope) was reported.

Countries

United States

Participant flow

Recruitment details

A total of 176 subjects were enrolled in this study. Of those enrolled, 171 subjects were dispensed the study lens, while 5 subjects failed to meet all eligibility criteria. Of those dispensed, 163 subjects completed the study while 8 subjects were discontinued.

Participants by arm

ArmCount
Myopes
Subjects were classified as Myopic if the distance spherical equivalent refraction was in the range of -1.25 D to -3.75 D.
105
Hyperopes
Subjects were classified as Hyperopic if the distance spherical equivalent refraction was in the range of +1.25 D to +4.25 D.
66
Total171

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyIncorrect Lens Dispensed2
Overall StudyLost to Follow-up1
Overall StudyProtocol Violation1
Overall StudyUnsatisfactory Lens Fitting due to Test Article2
Overall StudyUnsatisfactory Visual Response due to Test Article2

Baseline characteristics

CharacteristicMyopesTotalHyperopes
Age, Continuous49.9 Years
STANDARD_DEVIATION 6.89
53.5 Years
STANDARD_DEVIATION 7.97
59.1 Years
STANDARD_DEVIATION 6.1
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants2 Participants0 Participants
Race (NIH/OMB)
Black or African American
9 Participants12 Participants3 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
93 Participants155 Participants62 Participants
Region of Enrollment
United States
105 Participants171 Participants66 Participants
Sex: Female, Male
Female
68 Participants119 Participants51 Participants
Sex: Female, Male
Male
37 Participants52 Participants15 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 171
other
Total, other adverse events
0 / 171
serious
Total, serious adverse events
0 / 171

Outcome results

Primary

CLUE Vision Scores

Subjective vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The average CLUE vision score for each sphere stratum (Hyperope and Myope) was reported.

Time frame: 2-Week Follow-up

Population: All dispensed subjects regardless of deviation from protocol with data collected at the 2-week follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Test (Senofilcon A C3)CLUE Vision ScoresMyopes61.13 Units on a ScaleStandard Deviation 21.181
Test (Senofilcon A C3)CLUE Vision ScoresHyperopes56.19 Units on a ScaleStandard Deviation 18.634
Comparison: It was calculated using a 1-sided one-sample mean t-test with a family wise type I error rate of 5% with at least 99% statistical power, that 23 and 29 subjects were required to test for superiority for CLUE vision scores for hyperopes and myopes, respectively.95% CI: [56.7, 67.5]Mixed Model Analysis
Comparison: It was calculated using a 1-sided one-sample mean t-test with a family wise type I error rate of 5% with at least 99% statistical power, that 23 and 29 subjects were required to test for superiority for CLUE vision scores for hyperopes and myopes, respectively.95% CI: [51.7, 64]Mixed Model Analysis
Primary

HLHC Binocular logMAR Visual Acuities

Binocular visual acuity was measured on a logMAR (Logarithm of Minimal Angle of Resolution) scale under high luminance high contrast condition. At distance (4 meters), VA is assessed using ETDRS (Early Treatment Diabetic Retinopathy Study) charts; while near (40 cm) and intermediate (64 cm) assessments were made using reduced Guillon-Poling charts. Letter-by-letter results calculated the visual performance score for each chart read. LogMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR visual performance score of 0.0 is equivalent to Snellen visual acuity of 20/20. Data from hyperopes and myopes were combined for this outcome since logMAR scores between the two populations are similar.

Time frame: 2-Week Follow-up

Population: All dispensed subjects regardless of deviation from protocol with data collected at the 2-week follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Test (Senofilcon A C3)HLHC Binocular logMAR Visual AcuitiesDistance (4m)-0.088 logMARStandard Deviation 0.0874
Test (Senofilcon A C3)HLHC Binocular logMAR Visual AcuitiesNear (40cm)0.087 logMARStandard Deviation 0.1103
Test (Senofilcon A C3)HLHC Binocular logMAR Visual AcuitiesIntermediate (64cm)-0.018 logMARStandard Deviation 0.1106
Comparison: It was calculated using a 1-sided one-sample mean t-test with a family wise type I error rate of 5% with at least 99% statistical power, that 9, 6 and 29 subjects were required to test the primary hypotheses for distance, intermediate and near, respectively.95% CI: [-0.115, -0.056]Mixed Model Analysis
Comparison: It was calculated using a 1-sided one-sample mean t-test with a family wise type I error rate of 5% with at least 99% statistical power, that 9, 6 and 29 subjects were required to test the primary hypotheses for distance, intermediate and near, respectively.95% CI: [-0.05, 0.005]Mixed Model Analysis
Comparison: It was calculated using a 1-sided one-sample mean t-test with a family wise type I error rate of 5% with at least 99% statistical power, that 9, 6 and 29 subjects were required to test the primary hypotheses for distance, intermediate and near, respectively.95% CI: [0.051, 0.116]Mixed Model Analysis
Primary

Proportion of Eyes With Absolute Rotation Less Than or Equal to 10 Degrees

Absolute rotation was assessed for each subject eye using a slit lamp 15-minutes after lens insertion. Acceptable absolute rotation was dichotomized into a binary response where Y=1 if absolute rotation was less than or equal to 10 degrees and Y=0 otherwise (absolute rotation greater than 10 degrees). The proportion of eyes with absolute rotation less than or equal to 10 degrees was report for each lens.

Time frame: 15-minutes after lens insertion

Population: All dispensed subjects regardless of subsequent withdrawal from study or deviation from protocol.

ArmMeasureValue (NUMBER)
Test (Senofilcon A C3)Proportion of Eyes With Absolute Rotation Less Than or Equal to 10 Degrees0.9474 Proportion of eyes
Comparison: It was calculated using a Bayesian beta-binomial model for correlated data with a reference rate of 0.902 and an intraclass correlation of 0.70, that 140 subjects were required to test for superiority to achieve a minimum statistical power of 96% with 95% central posterior credible interval.95% CI: [0.908, 0.968]Bayesian beta-binomial model
Primary

Proportion of Eyes With Grade 3 or Higher Slit Lamp Findings

Slit Lamp Findings (SLF) were assessed using a biomicroscope and was graded using the FDA grading scale (Grade: 0, 1,2, 3 and 4) with grade 0 represents the absence of findings and 1 to 4 representing successively worse findings (i.e. Grade 1 = trace, Grade 2 = Mild, Grade 3 = moderate and Grade 4 = severe). This was performed on each subject eye at every study visit (baseline, unscheduled visits and 1-week follow-up). The data was then dichotomized into two groups. Those with grade 3 or higher and those with grade 2 or lower. The proportion of eyes with SLF with grade 3 or higher was reported. Data from the hyperope and myopes group were combined for this outcome since the rate of SFLs grade 3+ is similar for these two populations.

Time frame: Up to 2-Week Follow-up

Population: All dispensed subjects regardless of subsequent withdrawal from study or deviation from protocol.

ArmMeasureValue (NUMBER)
Test (Senofilcon A C3)Proportion of Eyes With Grade 3 or Higher Slit Lamp Findings0.0029 Proportion of eyes
Comparison: It was calculated that 140 subjects were required to test for superiority to achieve a minimum statistical power of 99% with 95% central posterior credible.95% CI: [0, 0.017]Bayesian beta-binomial model
Primary

Proportion of Eyes With Rotational Stability Less Than or Equal to 5 Degrees

Rotational Stability was assessed for each subject eye using a slit lamp 15-minutes after lens insertion. Rotational Stability was dichotomized into a binary response where Y=1 if Rotational Stability was less than or equal to 5 degrees and Y=0 otherwise (Rotational Stability greater than 5 degrees). The proportion of eyes with Rotational Stability less than or equal to 5 degrees was report for each lens.

Time frame: 15-minutes after lens insertion

Population: All dispensed subjects regardless of subsequent withdrawal from study or deviation from protocol.

ArmMeasureValue (NUMBER)
Test (Senofilcon A C3)Proportion of Eyes With Rotational Stability Less Than or Equal to 5 Degrees1 Proportion of eyes
Comparison: It was calculated using a Bayesian beta-binomial model for correlated data with a reference rate of 0.99 and an intraclass correlation of 0.70, that 140 subjects were required to test for superiority to achieve a minimum statistical power of 96% with 95% central posterior credible interval.95% CI: [0.974, 0.997]Bayesian beta-binomial model
Primary

Proportion of Eyes With Unacceptable Lens Fitting

Contact lens fitting acceptance was assessed for each subject eye using a biomicroscope post lens insertion at the 1-week follow-up. Lens fit was a binary variable where unacceptable lens fit=1 and acceptable lens fit=0. The proportion of eyes with unacceptable lens fit was reported. Data from the hyperope and myopes group were combined for this outcome since lens fitting characteristics are similar for these two populations.

Time frame: Up to 2-Week Follow-up

Population: All dispensed subjects regardless of subsequent withdrawal from study or deviation from protocol.

ArmMeasureValue (NUMBER)
Test (Senofilcon A C3)Proportion of Eyes With Unacceptable Lens Fitting0 Proportion of eyes
Comparison: It was calculated that 140 subjects were required to test for superiority to achieve a minimum statistical power of 99% with 95% central posterior credible.95% CI: [0, 0.011]Bayesian beta-binomial model
Secondary

CLUE Comfort Scores

Subjective comfort was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The average CLUE comfort scores for each sphere stratum (Hyperope and Myope) were reported.

Time frame: 2-Week Follow-up

Population: All dispensed subjects regardless of deviation from protocol with data collected at the 2-week follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Test (Senofilcon A C3)CLUE Comfort ScoresMyopes63.63 Units on a ScaleStandard Deviation 22.498
Test (Senofilcon A C3)CLUE Comfort ScoresHyperopes62.56 Units on a ScaleStandard Deviation 20.732
Comparison: It was calculated using a one-sided one-sample mean t-test with a family wise type I error rate of 5% with at least 99% statistical power, that 23 and 46 subjects were required to test for superiority for CLUE comfort scores for hyperopes and myopes, respectively.95% CI: [58.6, 70.8]Mixed Model Analysis
Comparison: It was calculated using a one-sided one-sample mean t-test with a family wise type I error rate of 5% with at least 99% statistical power, that 23 and 46 subjects were required to test for superiority for CLUE comfort scores for hyperopes and myopes, respectively.95% CI: [59, 69.5]Mixed Model Analysis
Secondary

CLUE Handling Scores

Subjective handling was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The average CLUE handling scores for each sphere stratum (Hyperope and Myope) were reported.

Time frame: 2-Week Follow-up

Population: All dispensed subjects regardless of deviation from protocol with data collected at the 2-week follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Test (Senofilcon A C3)CLUE Handling ScoresMyopes68.03 Units on a ScaleStandard Deviation 19.455
Test (Senofilcon A C3)CLUE Handling ScoresHyperopes67.88 Units on a ScaleStandard Deviation 20.677
Comparison: It was calculated using a one-sided one-sample mean t-test with a family wise type I error rate of 5% with at least 99% statistical power, that 15 and 26 subjects were required to test for superiority for CLUE handling scores for hyperopes and myopes, respectively.95% CI: [62.2, 73.5]Mixed Model Analysis
Comparison: It was calculated using a one-sided one-sample mean t-test with a family wise type I error rate of 5% with at least 99% statistical power, that 15 and 26 subjects were required to test for superiority for CLUE handling scores for hyperopes and myopes, respectively.95% CI: [62.2, 71.8]Mixed Model Analysis
Secondary

CLUE Vision Scores

Subjective vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The average CLUE vision score for each sphere stratum (Hyperope and Myope) was reported.

Time frame: 2-Week Follow-up

Population: All dispensed subjects regardless of deviation from protocol with data collected at the 2-week follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Test (Senofilcon A C3)CLUE Vision ScoresMyopes61.13 Units on a ScaleStandard Deviation 21.181
Test (Senofilcon A C3)CLUE Vision ScoresHyperopes56.19 Units on a ScaleStandard Deviation 18.634
Comparison: It was calculated using a one-sided one-sample mean t-test with a family wise type I error rate of 5% with at least 99% statistical power, that 42 and 55 subjects were required to test for superiority for CLUE vision scores for hyperopes and myopes, respectively.95% CI: [51.7, 64]Mixed Model Analysis
Comparison: It was calculated using a one-sided one-sample mean t-test with a family wise type I error rate of 5% with at least 99% statistical power, that 42 and 55 subjects were required to test for superiority for CLUE vision scores for hyperopes and myopes, respectively.95% CI: [56.7, 67.5]Mixed Model Analysis
Secondary

Proportion of Subject Achieving Optimal Lens Pair in 4 Lenses or Less.

The number of lenses to achieve the optimal pair for each subject was calculated as the original pair (2) plus all the required modifications to reach the optimal pair. In this study the minimum number of lenses per subject used was 2 where the maximum possible number of lenses used was 10. The data was dichotomized as Y=1 if the subject was able to achieve optimal lens pair in 4 lenses or lenses or less and 0 otherwise. A lens modification was performed if the subject reports unsatisfactory vision or was unable to obtain 20/30 distance visual acuity in both eyes. If the subject reported satisfactory vision with the lenses a modification was not required. However, based upon the investigator's findings on the measured visual acuity and/or over- refraction a modification may have been performed. Data for the hyperope and myope groups were combined for this endpoint since the number of subjects needed to optimize vision is independent of which group a subject belongs to.

Time frame: Up to 1-Week Follow-up

Population: All dispensed subjects regardless of subsequent withdrawal from study or deviation from protocol.

ArmMeasureValue (NUMBER)
Test (Senofilcon A C3)Proportion of Subject Achieving Optimal Lens Pair in 4 Lenses or Less.0.971 Proportion of Subjects
Comparison: It was calculated using a Bayesian beta-binomial model for correlated data with a reference rate of 0.99 and an intraclass correlation of 0.70 with 5000 replicating trials, that 140 subjects were required to test for superiority to achieve a minimum statistical power of 99% with 95% central posterior credible.95% CI: [0.933, 0.988]Bayesian beta-binomial model

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026